Innoviva, Inc.
INVA
$21.19
$0.442.12%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
4/9/2026
-
MarketBeat
8/15/2026
-
Simply Wall St
8/14/2026
-
MarketBeat
8/12/2026
-
MarketBeat
8/11/2026
-
Business Wire
8/10/2026
-
The Cerbat Gem
8/8/2026
-
Simply Wall St
8/7/2026
-
TipRanks: TheFly
8/7/2026
-
MarketBeat
8/6/2026
-
Simply Wall St
8/6/2026
-
Seeking Alpha - Healthcare
8/6/2026
-
SeekingAlpha
8/6/2026
-
MarketBeat
8/6/2026
-
Zacks Investment Research
8/5/2026
-
TipRanks: TheFly
8/5/2026
-
Business Wire
8/4/2026
-
Zacks Investment Research
8/3/2026
-
MarketBeat
8/3/2026
-
MarketBeat
8/2/2026
-
MarketBeat
8/1/2026
-
MarketBeat
7/29/2026
-
MarketBeat
7/28/2026
-
MarketBeat
7/9/2026
-
MarketBeat
1/8/2026
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, August 5, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 2 and 6 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 238 9600
Address
1350 Old Bayshore Highway
Suite 400
Burlingame, CA 94010
Suite 400
Burlingame, CA 94010
Country
Year Founded
Business Description
Sector
Innoviva, Inc. operates as a biopharmaceutical company in the United States and internationally. Its royalty portfolio includes RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting...
more